The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment
Demuth, Christina, Madsen, Anne Tranberg, Weber, Britta, Wu, Lin, Meldgaard, Peter, Sorensen, Boe SandahlVolume:
18
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-018-4108-0
Date:
December, 2018
File:
PDF, 347 KB
english, 2018